US HB1499 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 38-1)
Status: Introduced on March 5 2019 - 25% progression, died in chamber
Action: 2019-05-10 - Placed on the Union Calendar, Calendar No. 30.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 5 2019 - 25% progression, died in chamber
Action: 2019-05-10 - Placed on the Union Calendar, Calendar No. 30.
Text: Latest bill text (Introduced) [PDF]
Summary
To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.
Title
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsors
Rep. Bobby Rush [D-IL] | Rep. Frank Pallone [D-NJ] | Rep. Raul Ruiz [D-CA] | Rep. Debbie Dingell [D-MI] |
Rep. Angela Craig [D-MN] | Rep. Anna Eshoo [D-CA] | Rep. Joseph Kennedy [D-MA] | Rep. Doris Matsui [D-CA] |
Rep. Jeff Van Drew [R-NJ] | Rep. Yvette Clarke [D-NY] | Rep. Ro Khanna [D-CA] | Rep. Janice Schakowsky [D-IL] |
Rep. Christopher Pappas [D-NH] | Rep. Steve Cohen [D-TN] | Sen. Peter Welch [D-VT] | Rep. John Larson [D-CT] |
Rep. Alcee Hastings [D-FL] | Rep. Joseph Neguse [D-CO] | Rep. Abby Finkenauer [D-IA] | Rep. Ed Case [D-HI] |
Rep. Mike Quigley [D-IL] | Rep. Susan Wild [D-PA] | Rep. James Langevin [D-RI] | Rep. Jim Cooper [D-TN] |
Rep. Jamie Raskin [D-MD] | Rep. David Scott [D-GA] | Rep. Debbie Mucarsel-Powell [D-FL] | Rep. Bennie Thompson [D-MS] |
Rep. Haley Stevens [D-MI] | Rep. Gil Cisneros [D-CA] | Rep. Robin Kelly [D-IL] | Rep. Sean Casten [D-IL] |
Rep. Chrissy Houlahan [D-PA] | Rep. Andre Carson [D-IN] | Rep. Salud Carbajal [D-CA] | Rep. Sharice Davids [D-KS] |
Rep. Adam Smith [D-WA] | Rep. Gerald Connolly [D-VA] | Rep. Lauren Underwood [D-IL] |
History
Date | Chamber | Action |
---|---|---|
2019-05-10 | House | Placed on the Union Calendar, Calendar No. 30. |
2019-05-10 | House | Committee on the Judiciary discharged. |
2019-05-10 | House | Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-52, Part I. |
2019-04-08 | House | Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. |
2019-04-03 | House | Ordered to be Reported (Amended) by Voice Vote. |
2019-04-03 | House | Committee Consideration and Mark-up Session Held. |
2019-03-27 | House | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . |
2019-03-27 | House | Subcommittee Consideration and Mark-up Session Held. |
2019-03-06 | House | Referred to the Subcommittee on Health. |
2019-03-05 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-03-05 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-03-05 | House | Introduced in House |
Same As/Similar To
HB987 (Related) 2019-05-20 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB2700 (Related) 2019-06-26 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
HB2700 (Related) 2019-06-26 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Subjects
Administrative law and regulatory procedures
Civil actions and liability
Competition and antitrust
Federal Trade Commission (FTC)
Government information and archives
Health
Intellectual property
Judicial review and appeals
Prescription drugs
Civil actions and liability
Competition and antitrust
Federal Trade Commission (FTC)
Government information and archives
Health
Intellectual property
Judicial review and appeals
Prescription drugs